Whole Exome Sequencing and National Taiwan University Next-Generation Neuromuscular Disease Panel
Hello, Dr.
Jian.
I have been experiencing weakness in my limbs for over a year, and the neurology department has not been able to provide a diagnosis.
I am considering genetic testing.
If I have already undergone whole exome sequencing, do I still need to do the next-generation neuromuscular disease panel from National Taiwan University? Or does the whole exome sequencing already cover the genes tested in this panel? Alternatively, is the panel more comprehensive and precise than whole exome sequencing?
Niming, 20~29 year old female. Ask Date: 2021/10/18
Dr. Jian Yingxiu reply Rare Disease
Hello: From a technical standpoint, the whole exome sequencing used in the National Taiwan University next-generation neuromuscular disease panel employs the same technology.
If you have already undergone whole exome sequencing, there is no need to repeat the National Taiwan University next-generation neuromuscular disease panel.
However, the specific circumstances should be determined based on your report and your medical condition.
Please bring your report to a genetic counseling center for further discussion and confirmation.
Thank you.
Reply Date: 2021/10/18
More Info
When considering whether to undergo a next-generation neuromuscular disease panel after having already completed exome sequencing, it is essential to understand the differences between these two genetic testing approaches and their implications for diagnosis and treatment.
Exome sequencing focuses on the protein-coding regions of the genome, which represent about 1-2% of the entire genome but contain approximately 85% of known disease-causing mutations. This method can identify a wide range of genetic variants associated with various conditions, including neuromuscular diseases. However, it may not capture all relevant mutations, particularly those in non-coding regions or structural variations that can also contribute to disease.
On the other hand, a next-generation neuromuscular disease panel is specifically designed to test for a curated list of genes known to be associated with neuromuscular disorders. These panels often include genes that may not be covered comprehensively by exome sequencing. They can also provide a more focused approach, potentially leading to quicker and more accurate diagnoses for specific neuromuscular conditions.
Here are some considerations to help you decide whether to pursue the neuromuscular disease panel:
1. Previous Testing Results: If your exome sequencing did not yield a conclusive diagnosis, a targeted neuromuscular panel might be beneficial. These panels are designed to detect mutations in genes that are commonly associated with neuromuscular diseases, which might have been missed in broader testing.
2. Clinical Symptoms: Given that you have experienced muscle weakness for over a year without a definitive diagnosis, a neuromuscular disease panel could help narrow down potential causes. If your symptoms align with specific neuromuscular disorders, the panel may provide insights that guide further management.
3. Genetic Counseling: Consulting with a genetic counselor or a specialist in genetics can provide clarity on the potential benefits of additional testing. They can help interpret previous results and discuss the likelihood of finding a diagnosis through the neuromuscular panel.
4. Cost and Insurance Coverage: Consider the financial implications of additional testing. Some insurance plans may cover the costs of targeted panels, especially if there is a strong clinical indication. It’s worth checking with your provider.
5. Advancements in Genetic Testing: Genetic testing technology is rapidly evolving. Next-generation sequencing techniques may offer improved sensitivity and specificity compared to traditional methods. If the neuromuscular panel utilizes advanced technology, it might provide a more comprehensive analysis than what was achieved through exome sequencing.
6. Family History: If there is a family history of neuromuscular diseases, this may warrant further testing. A targeted panel could identify hereditary conditions that may not have been evident in your exome results.
In conclusion, while exome sequencing is a powerful tool, it may not encompass all the genetic factors related to neuromuscular diseases. A next-generation neuromuscular disease panel could provide additional insights and potentially lead to a diagnosis that can guide treatment options. It is advisable to discuss this with your healthcare provider, who can help you weigh the pros and cons based on your specific situation and medical history.
Similar Q&A
Understanding the Need for Specialized Genetic Testing Kits in Rare Diseases
Hello Dr. Jian, regarding the previously mentioned issue of "whole exome sequencing and the NTU next-generation neuromuscular testing panel," if whole exome sequencing encompasses the genes tested in the neuromuscular panel, why does NTU still offer various panels such ...
Dr. Jian Yingxiu reply Rare Disease
Hello: Each test has its own advantages and disadvantages, as well as its own validation results. Therefore, it is still necessary for clinical physicians to assess the individual case and determine the appropriate tests that meet the needs. Thank you.[Read More] Understanding the Need for Specialized Genetic Testing Kits in Rare Diseases
Tracking Genetic Mutations in Muscle Atrophy: Causes and Prevention
My son, who is in the third year of junior high school, has been experiencing symptoms progressively. Initially, the most noticeable issue was frequent falls. As parents, we often thought it was just a case of him being clumsy while walking. Later, he also began to struggle with ...
Dr. Chen Shunsheng reply Rare Disease
In the country, genetic diagnosis for progressive muscular atrophy is relatively rare. Currently, related genetic diagnosis and treatment are conducted through international collaboration, with most specimens being sent to Japan or the United States for testing.[Read More] Tracking Genetic Mutations in Muscle Atrophy: Causes and Prevention
Exploring Neuromuscular Disorders: What to Do When Tests Come Back Normal
Hello doctor, I have been experiencing weakness in my limbs for over a year, and I am very concerned that it might be a rare neuromuscular disease. I have visited many major hospitals and undergone neurological examinations each time I saw a different doctor. I had an MRI of the ...
Dr. Jiang Junyi reply Neurology
Hello, sir: I am not sure if there is a medical center near your residence. Due to the nature of neurological disease examinations, they require a period of follow-up for comparison. For instance, if a score drops from 80 to 70, it may still be considered passing from a 60-point ...[Read More] Exploring Neuromuscular Disorders: What to Do When Tests Come Back Normal
Exploring Genetic Testing for Rare Diseases: Beyond Wilson's Disease
Hello Doctor: Previously, I experienced involuntary hand tremors that caused significant distress, so I consulted a neurologist. Blood test results showed low levels of copper and ceruloplasmin, raising suspicion for Wilson's disease. The doctor recommended that I undergo fu...
Dr. Lai Xiangrong reply Rare Disease
Wilson's disease genetic testing is currently available at the Changhua Christian Hospital Genetic Counseling Center, the Genetic Medicine Department of the National Taiwan University Hospital, and the Molecular Biology Section of the Laboratory Medicine Department at China ...[Read More] Exploring Genetic Testing for Rare Diseases: Beyond Wilson's Disease
Related FAQ
Whole Exome Sequencing
(Rare Disease)
Muscular Diseases(Rare Disease)
Newborn Screening(Rare Disease)
Neurology(Rare Disease)
Chromosomes(Rare Disease)
Congenital Metabolic Disorders(Rare Disease)
G6Pd Deficiency(Rare Disease)
Osteogenesis Imperfecta(Rare Disease)
Height(Rare Disease)
Ichthyosis(Rare Disease)